Stem Cell Innovations to supply PluriCells to Stanford researchers

By Elaine Rigoli

Tampa, Fla., Sept. 14 - Stem Cell Innovations, Inc. has signed an agreement to supply PluriCells to researchers at Stanford University for use in their laboratories.

The Houston cell biology company said PluriCells provide an alternative to embryonic stem cells and are available for use under broad-based government funding.

The company has previously presented data demonstrating its ability to grow PluriCells efficiently and reproducibly without feeder layers and said the cells may serve as an attractive alternative to embryonic stem cells in federally funded labs.

"We are very pleased to have concluded this agreement with Stanford, home to several of the leading stem cell scientists, and expect to use it as a model for future academic agreements. Our objective is to make our PluriCells widely available to researchers, on an institution-friendly basis, who can move stem cell biology forward in the United States, in their own labs and without the restrictions imposed by federal regulation," chief executive officer James H. Kelly said in a company news release.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.